Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
J Heart Lung Transplant ; 28(11): 1185-92, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19783182

ABSTRACT

BACKGROUND: Indoleamine 2,3-dioxygenase (IDO), an enzyme involved in the degradation of tryptophan (Try) to kynurenine (Kyn), is thought to suppress T-cell activity. Although a few experimental studies have suggested a role for IDO in graft acceptance, human data are scarce and inconclusive. We sought to establish whether, in lung transplant recipients (LTRs), plasma IDO activity mirrors the level of graft acceptance. METHODS: We measured the plasma Kyn/Try ratio, reflecting IDO activity, by high-performance liquid chromatography (HPLC) in 90 LTRs, including 26 patients who were still functionally/clinically stable for >36 post-transplant months (stable LTRs) and 64 LTRs with bronchiolitis obliterans syndrome (BOS, Grades 0-p to 3). Twenty-four normal healthy controls (NHCs) were also included. RESULTS: The Kyn/Try ratio in stable LTRs resembled that observed in NHCs, whereas, unexpectedly, patients with BOS, who had lower counts of peripheral CD4(+) T-regulatory cells and tolerogenic plasmacytoid dendritic cells than stable LTRs, showed an increased plasma Kyn/Try ratio compared with both NHCs and stable LTRs. IDO expression by in vitro-stimulated peripheral blood mononuclear cells (PBMC) did not vary between BOS and stable LTRs. Furthermore, BOS patients displayed signs of chronic systemic inflammation (increased plasma levels of interleukin-8 and tumor necrosis factor-alpha) and higher T-cell activation (increased frequency of peripheral interferon-gamma-producing clones). CONCLUSIONS: Our results suggest that, in vivo, in lung transplantation, plasma IDO activity does not reflect the degree of lung graft acceptance, but instead is correlated with the degree of chronic inflammation.


Subject(s)
Indoleamine-Pyrrole 2,3,-Dioxygenase/blood , Lung Transplantation/physiology , Transplantation Tolerance/physiology , Transplantation, Homologous/physiology , Biomarkers/blood , Bronchiolitis Obliterans/blood , Bronchiolitis Obliterans/enzymology , Chromatography, High Pressure Liquid , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Follow-Up Studies , Humans , Interleukin-8/blood , Kynurenine/blood , Postoperative Complications/blood , Postoperative Complications/enzymology , Reference Values , T-Lymphocyte Subsets/enzymology , Time Factors , Tryptophan/blood
2.
Hum Immunol ; 70(7): 477-86, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19332094

ABSTRACT

Radiofrequency thermal ablation (RFTA) is a local tumor-destructing technique that can potentially modulate the host immune response through mechanisms that are not clearly defined. We assessed whether RFTA could affect multiple systemic inflammatory and immunological parameters, including CD25+Foxp+ cells, in patients with primary or metastatic lung tumors. Three days after RFTA, a moderate and temporary systemic inflammatory response developed, as demonstrated by the increase in peripheral neutrophils and monocytes and in plasma levels of proinflammatory chemokines (MIP-1alpha, MIP-1beta, eotaxin, and interleukin[IL]-8) and acute phase reactants (complement C3 and C4, serum amyloid, alpha1 antichymotrypsin, and C-reactive protein). Moreover, we found a concomitant release of the anti-inflammatory factor IL-10. Thirty days after RFTA, a significant reduction in CD25+Foxp3+ counts with an increase in CD4+ T-cell proliferation and number of interferon-gamma-secreting cells was observed. The reduction in CD25+Foxp3+ cells lasted up to 90 days after treatment. The use of RFTA in lung cancer patients has an immunomodulatory activity: it induces a self-limiting systemic inflammation early and later a reduction of circulating CD25+Foxp3+ Tregs. In addition to tumor ablation, downmodulation of this regulatory subset might be an important mechanism involved in the long-term clinical efficacy of RFTA.


Subject(s)
Catheter Ablation/methods , Inflammation Mediators/blood , Lung Neoplasms/blood , Lung Neoplasms/surgery , T-Lymphocytes, Regulatory/cytology , Acute-Phase Proteins/analysis , Aged, 80 and over , Animals , Blood Proteins/analysis , Cell Proliferation , Cytokines/blood , Down-Regulation , Electrophoresis, Gel, Two-Dimensional , Enzyme-Linked Immunosorbent Assay , Female , Flow Cytometry , Forkhead Transcription Factors/blood , Humans , Interleukin-2 Receptor alpha Subunit/blood , Lung Neoplasms/pathology , Lymphocyte Count , Lymphocyte Subsets/cytology , Lymphocyte Subsets/metabolism , Male , Middle Aged , T-Lymphocytes, Regulatory/metabolism , Time Factors , Treatment Outcome
3.
J Proteome Res ; 8(5): 2331-40, 2009 May.
Article in English | MEDLINE | ID: mdl-19301896

ABSTRACT

The protein profiles of bronchoalveolar lavage fluid (BALf) of patients belonging to three selected subsets of Polymyositis/Dermatomyositis (PM/DM) have been compared by using a combination of 2-DE and MALDI-TOF/MS or LC-MS/MS. Our study examined the hypothesis that there were distinct differences in protein expression profiles that were related to the phenotype. From among the 323+/-51 protein spots that may represent the most highly expressed proteins in BALf of these patients, 24 unique spots were isolated and proteins identified. In particular, 9 spots were present in BALf of PM/DM patients only; 12 spots were exclusive of Overlap patients and 3 spots of AS patients. From among the proteins identified, a few were classified as cytoskeletal proteins, others were involved in oxidative stress and a number of proteins were associated with general metabolic activity or immunological response and inflammation. This is the first study in which evidence is provided that a number of different proteins are expressed in different subsets of PM/DM and supports our contention that the proteomic approach would be beneficial in discovering molecules which could represent possible prognostic factors of these rare pathologies.


Subject(s)
Bronchoalveolar Lavage Fluid/chemistry , Dermatomyositis/metabolism , Electrophoresis, Gel, Two-Dimensional/methods , Proteomics/methods , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Aged , Chromatography, Liquid , Cofilin 1/blood , Dermatomyositis/blood , Dermatomyositis/pathology , Gelsolin/blood , Humans , Immunoblotting , Middle Aged , Proteins/analysis , Proteins/classification , Proteins/metabolism , Reproducibility of Results , Tandem Mass Spectrometry , Vimentin/blood
4.
J Heart Lung Transplant ; 26(11): 1135-43, 2007 Nov.
Article in English | MEDLINE | ID: mdl-18022079

ABSTRACT

BACKGROUND: Bronchiolitis obliterans syndrome (BOS) affects long-term survival of lung transplant (Tx) recipients (LTRs), with no consistently effective treatment strategy. Identifying early markers of BOS is of paramount importance for improving graft survival. METHODS: We used 2-dimensional gel electrophoresis and protein identification by mass spectrometry to compare the protein profile of bronchoalveolar lavage fluid (BALf) in two groups of LTRs: one composed of patients with BOS and the other composed of patients with good graft function at >5 years post-surgery (stable LTRs). Based on the hypothesis that only proteins of lung origin could represent reliable BOS markers, we also evaluated paired plasma samples. Proteins of interest were also assessed in the BALf of control subjects and results confirmed by dot- blot analysis. RESULTS: Among 11 differentially expressed proteins, we identified 2 locally produced factors: peroxiredoxin II (PRXII), exclusively expressed in BOS; and surfactant protein A (SP-A), expressed consistently less in BOS patients than in stable LTRs. PRXII expression was never observed in BALf from control subjects, whereas SP-A was present in higher amounts compared with stable LTRs and BOS patients. Finally, the time course of SP-A was studied in 5 LTRs who subsequently developed BOS. A reduction in BALf SP-A content was detectable early after Tx, preceding BOS onset in 4 of 5 patients. CONCLUSIONS: Our results suggest that testing SP-A levels in BALf could predict LTR patients who are at higher risk of BOS development.


Subject(s)
Bronchiolitis Obliterans/metabolism , Bronchoalveolar Lavage Fluid/chemistry , Peroxiredoxins/metabolism , Proteome/analysis , Proteome/metabolism , Pulmonary Surfactant-Associated Protein A/metabolism , Adult , Aged , Biomarkers , Bronchiolitis Obliterans/complications , Bronchiolitis Obliterans/etiology , Case-Control Studies , Female , Graft Rejection/etiology , Humans , Lung Transplantation/adverse effects , Male , Middle Aged , Predictive Value of Tests , Risk Factors
5.
Blood ; 109(2): 632-42, 2007 Jan 15.
Article in English | MEDLINE | ID: mdl-16985181

ABSTRACT

CD4+CD25+ regulatory T lymphocytes (Tregs) are specialized T cells playing a key role in the control of immune homeostasis. Here, we show that human Tregs constitutively express tyrosine hydroxylase (TH, EC 1.14.16.2), the rate-limiting enzyme in the synthesis of catecholamines, and contain substantial amounts of dopamine, norepinephrine, and epinephrine, which are released upon treatment with reserpine. Catecholamine release results in reduced production of interleukin-10 and transforming growth factor-beta by Tregs, and in down-regulation of Treg-dependent inhibition of effector T-lymphocyte (Teff) proliferation, which occurs without affecting the production of tumor necrosis factor-alpha or interferon-gamma. Tregs and Teffs express on the cell membrane both D1-like and D2-like dopaminergic receptors to a similar extent (12%-29% of the cells). Catecholamine-dependent down-regulation of Tregs is, however, selectively reversed by pharmacological blockade of dopaminergic D1-like receptors, which in Tregs only (and not in Teffs) are also expressed at the level of mRNA and are functionally coupled to intracellular production of cAMP. These findings indicate that in human Tregs endogenous catecholamines subserve an autocrine/paracrine loop involving dopaminergic pathways and resulting in down-regulation of Treg function.


Subject(s)
Autocrine Communication/drug effects , Catecholamines/metabolism , Paracrine Communication/drug effects , Phytohemagglutinins/pharmacology , T-Lymphocytes, Regulatory/immunology , Tyrosine 3-Monooxygenase/biosynthesis , Autocrine Communication/immunology , CD4 Antigens/immunology , Cell Proliferation , Down-Regulation , Forkhead Transcription Factors/drug effects , Forkhead Transcription Factors/immunology , Humans , Interleukin-10/biosynthesis , Interleukin-2 Receptor alpha Subunit/immunology , Paracrine Communication/immunology , Phytohemagglutinins/immunology , RNA, Messenger/drug effects , RNA, Messenger/immunology , Reserpine/pharmacology , T-Lymphocytes/immunology , T-Lymphocytes, Regulatory/drug effects , T-Lymphocytes, Regulatory/enzymology , Transforming Growth Factor beta/biosynthesis , Tyrosine 3-Monooxygenase/immunology
6.
Sarcoidosis Vasc Diffuse Lung Dis ; 21(2): 111-8, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15281432

ABSTRACT

BACKGROUND AND AIM: Fibrosing alveolitis develops in up to 80% of systemic sclerosis patients (SSc) but progression to end stage fibrosis occurs in about 15% of cases. Mechanisms leading to the process remain mostly unknown. We compared cytokine profiles of broncho-alveolar lavage fluids (BAL-f) from patients with SSc associated interstitial lung disease (SSc-ILD) (n. 34), idiopathic pulmonary fibrosis (IPF) (n. 13), stage II sarcoidosis (n. 14) and 9 controls. METHODS: Interleukin (IL) 8, monocyte chemoattractant protein 1 (MCP-1), gamma-interferon (IFN-gamma), IL12, IL18 and IL10 and transforming growth factor-beta (TGF-beta) were assessed by ELISA in concentrated BAL-f. RESULTS: Levels of IL8 and MCP-1 were significantly elevated in SSc-ILD and in IPF as compared with controls (Mann Whitney test p < 0.05), while MCP-1 values were significantly lower in SSc-ILD than in IPF. A significant correlation between neutrophils and IL8 levels (p = 0.047), as well as between eosinophils and MCP-1 levels (p = 0.004) was also observed. IFN-gamma levels were slightly higher than normal only in sarcoidosis (p = 0.06), whereas IL12 levels increased both in sarcoidosis and SSc-ILD (p < 0.05). No differences were found in IL18 and TGF-beta levels. Finally, IL10 levels were higher in SSc-ILD and sarcoidosis than in controls and IPF (p < 0.05). CONCLUSION: BAL-f cytokine profile differentiates ILD associated with SSc from IPF. The lower expression of MCP-1 and the higher expression of the anti-fibrotic IL12 and the anti-inflammatory IL10, observed both in sarcoidosis and in SSc-ILD, could account for the better prognosis of these ILDs. Further longitudinal studies are required to confirm whether a different cytokine phenotype may be considered predictive of clinical outcome in SSc-ILD.


Subject(s)
Bronchoalveolar Lavage Fluid/immunology , Cytokines/analysis , Pulmonary Fibrosis/immunology , Sarcoidosis, Pulmonary/immunology , Scleroderma, Systemic/immunology , Adult , Aged , Bronchoalveolar Lavage Fluid/chemistry , Cytokines/immunology , Female , Humans , Lung Diseases, Interstitial/diagnosis , Lung Diseases, Interstitial/immunology , Male , Middle Aged , Predictive Value of Tests , Pulmonary Fibrosis/diagnosis , Sarcoidosis, Pulmonary/diagnosis , Scleroderma, Systemic/complications , Scleroderma, Systemic/diagnosis
7.
Transplantation ; 77(5): 762-6, 2004 Mar 15.
Article in English | MEDLINE | ID: mdl-15021844

ABSTRACT

BACKGROUND: The subset of CD4+CD25+ regulatory T cells, recently identified in humans, may play a central role in the regulation of immune tolerance to graft survival. METHODS: This study assesses the frequency and functional profile of CD4+CD25+CD69- cells in the peripheral blood of lung transplant recipients (>3 years from transplantation), 10 of whom were in a stable clinical condition and 11 of whom demonstrated chronic rejection (bronchiolitis obliterans syndrome). We also studied a group of seven healthy subjects. RESULTS: The frequency of CD4+ T cells expressing CD25 (CD4+CD25+) and the highest levels (CD25) were lower in patients with bronchiolitis obliterans syndrome compared with healthy subjects and subjects in a stable clinical condition (P < or = 0.01). Purified CD4+CD25+ cells exhibited a regulatory functional profile in vitro: they were hyporesponsive, suppressed the proliferation of CD4+CD25- cells, and produced interleukin-10. CONCLUSION: These results provide in vivo evidence that peripheral CD4+CD25+ T cells may represent an important regulatory subset in lung transplantation.


Subject(s)
CD4-Positive T-Lymphocytes/cytology , CD4-Positive T-Lymphocytes/immunology , Lung Transplantation/immunology , Adult , Aged , Bronchiolitis Obliterans/immunology , CD4 Lymphocyte Count , CD4-Positive T-Lymphocytes/chemistry , Female , Graft Rejection/immunology , Humans , Male , Middle Aged , Receptors, Interleukin-2/analysis , Treatment Outcome
8.
Drugs Aging ; 21(3): 167-86, 2004.
Article in English | MEDLINE | ID: mdl-14979735

ABSTRACT

Elderly patients are at increased risk of developing lower respiratory tract infections compared with younger patients. In this population, pneumonia is a serious illness with high rates of hospitalisation and mortality, especially in patients requiring admission to intensive care units (ICUs). A wide range of pathogens may be involved depending on different settings of acquisition and patient's health status. Streptococcus pneumoniae is the most common bacterial isolate in community-acquired pneumonia, followed by Haemophilus influenzae, Moraxella catarrhalis and atypical pathogens such as Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae. However, elderly patients with comorbid illness, who have been recently hospitalised or are residing in a nursing home, may develop severe pneumonia caused by multidrug resistant staphylococci or pneumococci, and enteric Gram-negative bacilli, including Pseudomonas aeruginosa. Moreover, anaerobes may be involved in aspiration pneumonia. Timely and appropriate empiric treatment is required in order to enhance the likelihood of a good clinical outcome, prevent the spread of antibacterial resistance and reduce the economic impact of pneumonia. International guidelines recommend that elderly outpatients and inpatients (not in ICU) should be treated for the most common bacterial pathogens and the possibility of atypical pathogens. The algorithm for therapy is to use either a selected beta-lactam combined with a macrolide (azithromycin or clarithromycin), or to use monotherapy with a new anti-pneumococcal quinolone, such as levofloxacin, gatifloxacin or moxifloxacin. Oral (amoxicillin, amoxicillin/clavulanic acid, cefuroxime axetil) and intravenous (sulbactam/ampicillin, ceftriaxone, cefotaxime) beta-lactams are agents of choice in outpatients and inpatients, respectively. For patients with severe pneumonia or aspiration pneumonia, the specific algorithm is to use either a macrolide or a quinolone in combination with other agents; the nature and the number of which depends on the presence of risk factors for specific pathogens. Despite these recommendations, clinical resolution of pneumonia in the elderly is often delayed with respect to younger patients, suggesting that optimisation of antibacterial therapy is needed. Recently, some new classes of antibacterials, such as ketolides, oxazolidinones and streptogramins, have been developed for the treatment of multidrug resistant Gram-positive infections. However, the efficacy and safety of these agents in the elderly is yet to be clarified. Treatment guidelines should be modified on the basis of local bacteriology and resistance patterns, while dosage and/or administration route of each antibacterial should be optimised on the basis of new insights on pharmacokinetic/pharmacodynamic parameters and drug interactions. These strategies should be able to reduce the occurrence of risk factors for a poor clinical outcome, hospitalisation and death.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Geriatrics , Respiratory Tract Infections/drug therapy , Aged , Aging/metabolism , Anti-Bacterial Agents/pharmacokinetics , Humans , Intestinal Absorption , Respiratory Tract Infections/etiology , Respiratory Tract Infections/microbiology , Tissue Distribution , Treatment Outcome
9.
Cell Signal ; 15(5): 511-7, 2003 May.
Article in English | MEDLINE | ID: mdl-12639714

ABSTRACT

The endozepine triakontatetraneuropeptide (TTN) induces intracellular calcium ([Ca(2+)](i)) changes and is chemotactic for human neutrophils (PMNs). Because interleukin-8 (IL-8) production is Ca(2+) dependent and can be induced by chemotactic stimuli, we have investigated the ability of TTN to induce IL-8 production in PMNs, as well as the signal transduction mechanisms involved. Our results show that TTN increases IL-8 release and IL-8 mRNA expression in a concentration- and time-dependent fashion, and these effects are prevented by the Ca(2+) chelator BAPTA-AM. TTN-induced [Ca(2+)](i) changes and IL-8 mRNA expression are sensitive to pertussis toxin, to the phospholipase C (PLC) inhibitor U73122 (but not to its inactive analogue U73343) and to the protein kinase C (PKC) inhibitor calphostin C. It is therefore suggested that TTN-induced IL-8 production in human PMNs results from a G protein-operated, PLC-activated [Ca(2+)](i) rise, and PKC contributes to this effect. These findings further support the possible role of TTN in the modulation of the inflammatory processes.


Subject(s)
Calcium/physiology , Egtazic Acid/analogs & derivatives , Interleukin-8/biosynthesis , Neuropeptides/pharmacology , Neutrophils/immunology , Peptide Fragments/pharmacology , Signal Transduction , Chelating Agents/pharmacology , Dose-Response Relationship, Drug , Egtazic Acid/pharmacology , Enzyme Inhibitors/pharmacology , Gene Expression Regulation , Humans , Interleukin-8/genetics , Kinetics , Neutrophils/drug effects , Pertussis Toxin/pharmacology , Protein Kinase C/antagonists & inhibitors , RNA, Messenger/biosynthesis , Signal Transduction/drug effects , Type C Phospholipases/antagonists & inhibitors
10.
Sarcoidosis Vasc Diffuse Lung Dis ; 19(1): 47-53, 2002 Mar.
Article in English | MEDLINE | ID: mdl-12002384

ABSTRACT

BACKGROUND: The aim of our study was to compare clinical and BAL features of patients with bronchiolitis obliterans organizing pneumonia (BOOP) with those of patients with usual interstitial pneumonia (UIP) and control subjects. PATIENTS AND METHODS: This study reports on 14 patients with idiopathic BOOP. Diagnosis was made upon histology. Lung function tests were mostly normal. Chest X-ray and CT showed always a patchy consolidation, often associated with ground glass pattern. BAL was performed for cytology and for ELISA assessment of several cytokines (IL8, ILI0, IL12, gamma-interferon, IL 18, monocyte chemoattractant protein- 1). RESULTS: Cytology of BAL in BOOP showed a pattern of lymphocytic alveolitis (Lymphocytes: 0.36 x 10(6)/ml) associated with an increase in neutrophil and eosinophil counts (0.13 and 0.04 x 10(6)/ml respectively). Mean BALf levels in pg/ml of MCP-1, IL12 and IL18 were significantly increased in BOOP with respect to controls and UIP patients, while in UIP patients only a significant increase of IL8, MCP-1 and IL18 with respect to controls was detected. In addition, BALf levels of IL10, an anti-inflammatory cytokine, were significantly higher in BOOP patients with respect to controls and UIP patients. CONCLUSION: These findings are consistent with a marked degree of macrophage and lymphocyte activation in BOOP with an expansion of T helper-1 response. The concomitant increase of IL10 could be related to a limitation of the inflammatory process and the fibrotic evolution typical of this clinical picture.


Subject(s)
Bronchoalveolar Lavage Fluid/chemistry , Cryptogenic Organizing Pneumonia/immunology , Cytokines/analysis , Lung Diseases, Interstitial/immunology , Bronchoalveolar Lavage Fluid/cytology , Bronchoalveolar Lavage Fluid/immunology , Case-Control Studies , Chemokine CCL2/analysis , Cryptogenic Organizing Pneumonia/diagnosis , Enzyme-Linked Immunosorbent Assay , Female , Humans , Interferon-gamma/analysis , Interleukins/analysis , Lung Diseases, Interstitial/diagnosis , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...